Back to Authors

Liviu, Malureanu

Mayo Clinic

Mayo Clinic

Citations 1

RanBP2/Nup358 is required for Topoisomerase II/alpha‐mediated DNA decatenation, proper chromosome segregation and tumor suppression
Deursen, Jan MA van, Dawlaty, Meelad M. , Liviu, Malureanu, Jeganathan, Karthik B.

The FASEB Journal | April 10, 2020 | Volume: 21 | Issue: 5 | Pages: No page available

10.1096/fasebj.21.5.a210 Get It

RanBP2/Nup358 is a component of the nucleocytoplasmic transport machinery that has been implicated in mitotic progression. To determine the physiological importance of RanBP2 and its role in mitosis we have generated a series of mice with graded reduction of RanBP2 levels. Mice with very low amounts of RanBP2 are viable and overtly normal, but develop severe aneuploidy. Their major mitotic abnormality is the formation of anaphase bridges, a defect linked to improper Topoisomerase II/alpha‐mediated decatenation of sister chromatids. We find that RanBP2 forms a complex with Topoisomerase II/alpha in mitosis and regulates its decatenation activity and localization to chromosomes. Furthermore, we find that RanBP2 deficient mice are prone to spontaneous and carcinogen‐induced tumors. Together, these data identify RanBP2 as a key regulator of Topoisomerase II/alpha‐mediated DNA decatenation and a suppressor of tumorigenesis.